KAETLYN THARP: Open Payments
NPI 1043986045 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 61 payments from 20 companies in 2025. Trend: 2023 $544 · 2024 $145 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $185 |
| Novo Nordisk Inc | 10 | $163 |
| AstraZeneca Pharmaceuticals LP | 4 | $159 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Lilly USA, LLC | 4 | $65 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Amgen Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $47 |
| UCB, Inc. | 1 | $43 |
| Corcept Therapeutics | 2 | $38 |
Products named: Ozempic, BREZTRI, UBRELVY, MOUNJARO, FARXIGA, NEXLETOL, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
